LOS GATOS, Calif., Nov. 26 /PRNewswire/ -- TriCipher, the experts in strong authentication, today announced that its MySignatureBook digital signing solution has been certified as compliant with the SAFE-BioPharma(TM) digital identity and signature standard.
MySignatureBook 1.1 is an online digital signature workflow solution that manages the collection and application of digital signatures to PDF documents using Adobe Reader. The ability to leverage SAFE-BioPharma credentials for signing allows MySignatureBook to manage the signature process for many regulated and highly sensitive documents that are incredibly common to the life sciences industry.
"Digital signatures that meet the SAFE-BioPharma digital standard are accepted by the FDA and meet legal signature standards across the EU and the European Economic Area," said Mollie Shields-Uehling, president and CEO, SAFE-BioPharma Association. "Compliance with the SAFE-BioPharma standard means our members and TriCipher customers can have confidence in MySignatureBook when it is used with SAFE-BioPharma credentials."
MySignatureBook 1.1, announced today, is the second major enhancement of the online digital signing solution and is already deployed across several companies in the pharmaceutical and healthcare industries. New features include a truly zero-footprint client option and the ability to sign and manage groups of documents for companies with high-volume signature requirements.
"We have worked closely with our major customers in the life sciences industry to develop the features in MySignatureBook 1.1," said John De Santis, president and CEO of TriCipher. "Certification with the SAFE-BioPharma standard underlines our commitment to industry standards and supporting the pharmaceutical and healthcare communities."
TriCipher and SAFE-BioPharam will host a joint webcast on December 16th on
digital signatures in the pharma
|SOURCE TriCipher, Inc.|
Copyright©2008 PR Newswire.
All rights reserved